PTPRC and myelodysplastic syndrome: Diversely, SRSF2 mutant MDS is characterized by an increase of CD11b without CD16 expression, followed by an increase in CD16 expression without any further increase of CD11b expression (rectangle pattern) and only a dim CD45 expression in myeloid progenitor cells (152).